Menu Philippe 4
4 · SOPHiA GENETICS SA · Filed Apr 8, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CMO Philippe Menu Sells Shares
What Happened
Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), sold a total of 5,100 shares in two open-market transactions on April 6–7, 2026, generating approximately $24,773 in proceeds ($13,096 and $11,677). The trades were reported on a Form 4 filed April 8, 2026, and are coded as sales (S).
Key Details
- Transaction dates and reported weighted-average prices:
- 2026-04-06: 2,700 shares sold; reported avg price $4.85 (range: $4.62–$4.95). (Footnote F2)
- 2026-04-07: 2,400 shares sold; reported avg price $4.87 (range: $4.78–$4.98). (Footnote F3)
- Total shares sold: 5,100; total reported proceeds: $24,773 ($13,096 + $11,677).
- Reason/footnote: Sales were made to satisfy tax withholding obligations from RSU vesting on April 2 and 3, 2026, and were executed pursuant to a pre-established Rule 10b5-1 trading plan (Footnote F1) — not discretionary trades.
- Shares owned after the transactions: Not disclosed in the filing.
- Filing timeliness: Form 4 filed April 8, 2026; no late-filing indication in the report.
Context
These were tax-withholding sales tied to restricted stock unit vesting and executed under a 10b5-1 plan. Such routine withholding sales are generally considered administrative (not a directional bet on the stock). The filing notes weighted-average prices and provides price ranges; the reporting person offers to supply a per-price breakdown on request.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-04-06$4.85/sh−2,700$13,096→ 283,852 total - Sale
Ordinary Shares
[F1][F3]2026-04-07$4.87/sh−2,400$11,677→ 281,452 total
Footnotes (3)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.62 to $4.95, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.78 to $4.98, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.